Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 4/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | EBP | Q15125 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3301329 | 1.00 | MEN1 (0.61) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| Sulfuric Acid SCHEMBL9223828 | 0.89 | MEN1 (0.51) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11629435 | 0.89 | KCNH2 (0.50) | MEN1KMT2AKCNH2KDM4ECYP1A2 | |
| SCHEMBL11629438 | 0.89 | KCNH2 (0.50) | MEN1KMT2AKCNH2KDM4ECYP1A2 | |
| SCHEMBL9779068 | 0.87 | MEN1 (0.53) | MEN1KMT2AKCNH2KDM4EHTR2A | |
| SCHEMBL2774559 | 0.87 | MEN1 (0.63) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL2774560 | 0.87 | MEN1 (0.63) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| Hydrochloric Acid SCHEMBL8070534 | 0.86 | MEN1 (0.51) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11387658 | 0.84 | KCNH2 (0.47) | MEN1KMT2AKCNH2KDM4EL3MBTL1 | |
| SCHEMBL11496361 | 0.84 | EPOR (0.52) | MEN1KMT2AKCNH2L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12338374-B2 | Pressure sensitive adhesive composition and protective film employing the same | TSRC CORPORATION (TW) | 2025-06-24 | — | — | US | claimed |
| US-20240425635-A1 | METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SEKISUI CHEMICAL CO., LTD. (JP) | 2024-12-26 | — | — | US | claimed |
| US-12110355-B2 | Method for producing conjugated diene polymer | SEKISUI CHEMICAL CO., LTD. (JP) | 2024-10-08 | — | — | US | claimed |
| CN-113348184-B | Process for producing conjugated diene polymer | 积水化学工业株式会社 | 2023-10-27 | — | — | CN | claimed |
| US-20230312606-A1 | MCL-1 INHIBITOR FORMULATIONS | AMGEN INC. (US) | 2023-10-05 | — | — | US | claimed |
| EP-4203922-A1 | MCL-1 INHIBITOR FORMULATIONS | Amgen Inc. (US) | 2023-07-05 | — | — | EP | claimed |
| CN-116113473-A | MCL-1 inhibitor formulations | 安进公司 | 2023-05-12 | — | — | CN | claimed |
| EP-3770186-B1 | METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SEKISUI CHEMICAL CO LTD (JP) | 2022-08-24 | — | — | EP | claimed |
| CN-109148796-B | Acid scavenging functional diaphragm for lithium ion electrochemical cell functional performance | 通用汽车环球科技运作有限责任公司 | 2022-01-25 | — | — | CN | claimed |
| US-20210395421-A1 | METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SEKISUI CHEMICAL CO., LTD. (JP) | 2021-12-23 | — | — | US | claimed |
| WO-2003011205-A2 | ENCAPSULATION PRODUCTS FOR CONTROLLED OR EXTENDED RELEASE | CAPRICORN PHARMA, INC. (US) | 2003-02-13 | — | — | WO | claimed |
| US-20020128349-A1 | Liquid inks comprising a stable organosol | S-PRINTING SOLUTION CO., LTD. (KR) | 2002-09-12 | — | — | US | claimed |
| EP-1229057-A2 | Organosol and liquid inks comprising the same | Samsung Electronics Co., Ltd. (KR) | 2002-08-07 | — | — | EP | claimed |
| EP-1205815-A1 | Liquid inks comprising surface-treated colorant particles and manufacturing method thereof | Samsung Electronics Co., Ltd. (KR) | 2002-05-15 | — | — | EP | claimed |
| US-20020044962-A1 | Encapsulation products for controlled or extended release | CHERUKURI S RAO (US) | 2002-04-18 | — | — | US | claimed |
| US-5840329-A | GROUPS OF PARTICLES HAVING DISTINCT PATTERN OF DRUG RELEASE BASED ON COMBINATION OF CONTROLLED RELEASE LAYERS, SWELLING AGENTS AND COATINGS; CONTROLLED RELEASE LAYER OF SLIGHTLY CROSSLINKED POLYACRYLIC ACID AND WATER SOLUBLE POLYMER | BIOADVANCES LLC (US) | 1998-11-24 | — | — | US | claimed |
| WO-1998051287-A1 | PULSATILE DRUG DELIVERY SYSTEM | BAI JANE PEI FAN (US) | 1998-11-19 | — | — | WO | claimed |
| US-5244669-A | Multilayer coating | MITSUBISHI KASEI CORPORATION (JP) | 1993-09-14 | — | — | US | claimed |
| US-4246355-A | ACTIVATION OF AN INNER POLYMER MATRIX IMPREGNATED WITH FERROMAGNETIC MATERIAL, GRAFT POLYMERIZATION OF OUTER SHELL | ICI AUSTRALIA LIMITED (AU) | 1981-01-20 | — | — | US | claimed |
| US-3937798-A | METHOD OF CONTROLLING HYDROGEN ION CONCENTRATION BY MICROCAPSULES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-02-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312606-A1 | MCL-1 INHIBITOR FORMULATIONS | MCL1, BAK1, BCL2L1 | MEN1 58/4885KMT2A 376/4885KCNH2 3666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.